Design, synthesis, and anticancer evaluation of novel chalcone derivatives bearing piperazine and morpholine moieties

dc.contributor.authorÇalışkan, Nedime
dc.contributor.authorYılmaz, Fatih
dc.contributor.authorEyüpoğlu, Ozan Emre
dc.contributor.authorEmirik, Mustafa
dc.contributor.authorMenteşe, Emre
dc.date.accessioned2026-11-17T08:09:30Z
dc.date.issued2026
dc.departmentRTEÜ, Fen - Edebiyat Fakültesi, Kimya Bölümü
dc.departmentRTEÜ, Teknik Bilimler Meslek Yüksekokulu, Kimya ve Kimyasal İşleme Teknolojileri Bölümü
dc.description.abstractCancer remains one of the leading causes of mortality worldwide, highlighting the need for novel anticancer agents with improved efficacy and selectivity. In this study, a series of chalcone derivatives bearing phenylpiperazine, 2-fluorophenylpiperazine, and morpholine moieties (1a–g, 2a–g, and 3a–g) were designed, synthesized, and evaluated for their anticancer potential. The target compounds were synthesized via Claisen–Schmidt condensation under basic conditions and characterized by 1H NMR, 13C NMR, and elemental analysis. Their cytotoxic activities were assessed against PC-3, PANC-1, A549, and MCF-7 cancer cell lines using the MTT assay, with HEK-293 cells serving as a non-cancerous control. Most compounds exhibited notable antiproliferative activity and favorable selectivity compared with doxorubicin, cisplatin, and gemcitabine. Among the tested cell lines, A549 cells were the most sensitive. Compounds 2d, 2b, 2c, 2e, 2g, and 2a showed particularly potent activity against A549 cells, with IC50 values of 5.35 ± 0.08, 5.71 ± 0.09, 5.95 ± 0.09, 5.83 ± 0.09, 5.94 ± 0.09, and 5.96 ± 0.09 µM, respectively. Notably, 2c exhibited the highest selectivity toward A549 cells (SI = 3.26). SAR analysis indicated that the 2-fluorophenylpiperazine moiety enhanced anticancer activity, while halogen substitution generally improved potency and selectivity. Induced Fit Docking and Glide XP simulations supported these findings, suggesting that 2d and 2c achieve their activity through key hinge-region anchoring and isoform-specific interactions with PI3K-α and PI3K-γ. Overall, these findings identify fluorinated chalcone derivatives, particularly 2d, as promising leads for further anticancer drug development.
dc.identifier.citationÇalışkan, N., Yılmaz, F., Eyüpoğlu, O. E., Emirik, M., & Menteşe, E. (2026). Design, Synthesis, and Anticancer Evaluation of Novel Chalcone Derivatives Bearing Piperazine and Morpholine Moieties. Archiv der Pharmazie, 359(10), e70357. https://doi.org/10.1002/ardp.70357
dc.identifier.doi10.1002/ardp.70357
dc.identifier.issn0365-6233
dc.identifier.issue10
dc.identifier.scopus2-s2.0-105053022630
dc.identifier.scopusqualityQ2
dc.identifier.startpagee70357
dc.identifier.urihttps://doi.org/10.1002/ardp.70357
dc.identifier.urihttps://hdl.handle.net/11436/13809
dc.identifier.volume359
dc.indekslendigikaynakScopus
dc.institutionauthorÇalışkan, Nedime
dc.institutionauthorYılmaz, Fatih
dc.institutionauthorEmirik, Mustafa
dc.institutionauthorMenteşe, Emre
dc.institutionauthorid0000-0001-9489-9093
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofArchiv der Pharmazie
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAnticancer
dc.subjectchalcones
dc.subjectmolecular docking
dc.subjectmorpholine
dc.subjectpiperazine
dc.titleDesign, synthesis, and anticancer evaluation of novel chalcone derivatives bearing piperazine and morpholine moieties
dc.typeArticle

Dosyalar

Lisans paketi

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: